Stay updated on Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial page.

Latest updates to the Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial page
- Check8 days agoChange DetectedThe page now indicates that the study is no longer recruiting participants, and new help sections (How to Read a Study Record, Common Questions, How to Join a Study) have been added; the revision note updates to v3.6.0 and replaces the old v3.5.5 note, and the Intervention label is reformatted from 'Intervention / Treatment' to 'Intervention/Treatment'.SummaryDifference0.1%

- Check15 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous v3.5.4. This indicates a minor platform or template update rather than changes to the study content or layout.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedFooter now shows Revision: v3.5.4 in place of v3.5.3. This represents a minor update to the page template for the Study Details view rather than a change to the study content.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page now shows revision: v3.5.3, replacing the previous v3.5.2, indicating a minor version update to the page content. This update does not modify the study data, eligibility criteria, or recorded results.SummaryDifference0.0%

- Check65 days agoChange DetectedLocation entry updated from Temuco, Región de la Araucanía, Chile, 4810469 to Temuco, Araucania, Chile, 4810469, adding Araucania and removing the regional name. Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check80 days agoChange DetectedPadua, PD, Italy, 35100 was replaced with Padova, PD, Italy, 35100 for the study location.SummaryDifference0.0%

Stay in the know with updates to Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial page.